Published 16:51 IST, July 19th 2020
COVID-19: In a first, India’s Case Fatality Rate falls below 2.5%, informs Health Ministry
In a significant development, India's Coronavirus fatality rate has fallen below 2.5% for the first time, the government said on Sunday
Advertisement
In a significant development, India's Coronavirus fatality rate has fallen below 2.5% for first time, government said on Sunday. India's total COVID cases rose to 1,077,618 of which 373,379 are active while 677,422 have recovered. 26,816 people have died so far.
"With effective containment strategy, aggressive testing and standardized clinical manment protocols based on holistic Standard of Care approach, Case Fatality Rate has significantly dipped. Case Fatality Rate is progressively falling and currently, it is 2.49%. India has one of lowest fatality rates in world," Ministry of Health and Family Welfare said.
Ministry furr stated that many states have conducted population surveys to map and identify vulnerable population like elderly, pregnant women and those with co-morbidities. statement added that se surveys have ensured keeping high-risk population under continuous observation, thus aiding early identification, timely clinical treatment and reducing fatalities
Advertisement
Advertisement
Seven Indian Pharma Players Race To Develop COVID-19 Vaccine
Meanwhile, at least seven Indian pharma companies are working to develop a vaccine against coronavirus as y join global efforts to find a preventive to check spread of deadly virus that has already infected more than 14 million globally. Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immulogicals, Mynvax and Biological E are among domestic pharma firms working on coronavirus vaccines in India.
Vaccines rmally require years of testing and additional time to produce at scale, but scientists are hoping to develop a coronavirus vaccine within months because of pandemic.
Advertisement
Advertisement
16:51 IST, July 19th 2020